Bodycote (OTCMKTS:BYPLF - Get Free Report) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totaling 1,646 shares, a decrease of 82.8% from the March 31st total of 9,591 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 20 shares, the short-interest ratio is presently 82.3 days.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the company. Jefferies Financial Group reissued a "buy" rating on shares of Bodycote in a report on Friday, April 10th. Royal Bank Of Canada cut Bodycote from a "moderate buy" rating to a "hold" rating in a research note on Thursday, March 12th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy".
View Our Latest Stock Analysis on BYPLF
Bodycote Price Performance
Shares of BYPLF remained flat at $9.49 during mid-day trading on Friday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.02 and a current ratio of 1.17. The company has a 50-day moving average of $9.95 and a two-hundred day moving average of $9.21. Bodycote has a 52 week low of $9.49 and a 52 week high of $10.05.
Bodycote Company Profile
(
Get Free Report)
Bodycote plc OTCMKTS: BYPLF is a global provider of industrial thermal processing and materials technology services. The company offers a range of solutions including heat treatment, hot isostatic pressing, surface coatings and metal joining, all designed to enhance mechanical performance, improve material properties and extend the service life of critical components.
Operating more than 140 facilities across Europe, North America and the Asia-Pacific region, Bodycote serves customers in aerospace, automotive, energy, medical and general industrial markets.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bodycote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.
While Bodycote currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.